US2023124554A1PendingUtilityA1
Free-standing non-fouling polymers, their compositions, and related monomers
Est. expiryJun 2, 2035(~8.8 yrs left)· nominal 20-yr term from priority
Inventors:Shaoyi JiangTao BaiJean-René Ella-MenyeHsiang-Chieh HungPriyesh JainAndrew William SinclairHarihara Subramanian SundaramYang LiPeng Zhang
C08G 18/78C08F 220/603C08F 220/36C08F 220/34C09D 5/165C08G 2261/72C08G 2261/3342C08G 63/00C08G 61/06C08F 220/50C08F 220/48C08F 220/42C07C 265/04C07C 255/26C07C 229/12C08G 2261/62C08F 222/328C07C 237/22C07C 255/23C08G 2261/3324C09D 5/1637C08F 220/44C07C 253/30C07C 229/16C07F 9/091C09D 7/65C08G 61/12C09D 5/1662C08L 65/00C08G 2261/418C08G 2261/334C08G 2261/3321C08G 2261/228C08G 2261/1432C08G 2261/143C08G 2261/11C08G 61/08C08G 2261/1426C09D 165/00C09D 179/04C09D 179/02C09D 177/06C09D 175/04C09D 167/02C09D 135/02C08L 79/04C08L 79/02C08L 77/06C08L 75/04C08L 67/02C08L 35/02C08G 73/0611C08G 73/0233C08G 73/0226C08G 73/0206C08G 69/42C08G 69/26C08G 63/6856C08G 18/3821A61K 47/595A61K 47/593A61K 47/59A61K 47/58
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Free-standing non-fouling polymers and polymeric compositions, monomers and macromonomers for making the polymers and polymeric compositions, objects made from the polymers and polymeric compositions, and methods for making and using the polymers and polymeric compositions
Claims
exact text as granted — not AI-modifiedThe embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1 . A monomer having a formula selected from the group consisting of:
and wherein
R 1 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C 1 -C 20 alkyl, and C 6 -C 12 aryl groups, or CN;
R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of hydrogen, C 1 -C 20 alkyl, and C 6 -C 12 aryl, cyclic alkyl, fluoroalkyl, and void;
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening;
L is C or Si or void;
L 1 , L 3 , and L 4 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
L 2 is independently selected from —(CH 2 ) x —, or —(CH(CN)) x —, where x is an integer from 1 to 20;
A 1 is N;
B 1 is C, S, SO, PO, or PO 2 − ;
B 2 is C or SO;
C 1 is PO 4 ; and
M is selected from Cl, Br, I, SO 4 , NO 3 ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C 1 -C 20 alkyl), lactate, benzoate, and salicylate, or void.
2 . A monomer having a formula selected from the group consisting of:
wherein
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening;
L is C or Si or void;
L 1 , L 2 , L 3 , and L 4 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
A 1 is N;
B 1 is C, S, SO, PO, or PO 2 − ;
B 2 is C or SO;
C 1 is PO 4 ; and
M is selected from Cl, Br, I, SO 4 , NO 3 ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C 1 -C 20 alkyl), lactate, benzoate, and salicylate or void.
3 . A monomer having a formula selected from the group consisting of:
wherein
R 1 and R 6 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C20 alkyl, C6-C12 aryl, CN, cyclic alkyl, fluoro alkyl, and void;
R 4 , R 5 , R 7 , and R 8 are independently selected from the group consisting of hydrogen, C1-C20 alkyl, C6-C12 aryl, cyclic alkyl group, fluoro alkyl, and void;
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening;
L 0 and L 4 are C or Si or void;
L 1 , L 2 , L 3 , L 5 , and L 6 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
A 1 is N;
B 1 is C, S, SO, PO, or PO2-;
B 2 is C or SO;
C 1 is PO 4 ; and
M is selected from Cl, Br, I, SO 4 , NO 3 ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C1-C20 alkyl), lactate, benzoate, salicylate, or void.
4 . A macromonomer having a formula selected from the group consisting of:
and wherein
R 1 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C 1 -C 20 alkyl, C 6 -C 12 aryl, CN;
R 4 , R 5 , R 6 , and R 7 , are independently selected from the group consisting of hydrogen, C 1 -C 20 alkyl, C 6 -C 12 aryl, cyclic alkyl, fluoro alkyl, and void;
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening, or free radical polymerization;
L is C or Si or void;
L 1 , L 3 , and L 4 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
L 2 is independently selected from —(CH 2 ) x —, or —(CH(CN)) x —, where x is an integer from 1 to 20;
A 1 is N;
B 1 is C, S, SO, PO, or PO 2 − ;
B 2 is C or SO;
C 1 is PO 4 ;
M is selected from Cl, Br, I, SO 4 , NO 3 ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C 1 -C 20 alkyl), lactate, benzoate, salicylate, or void; and
j is an integer from 1 to about 1000.
5 . A macromonomer having a formula selected from the group consisting of:
wherein
R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of hydrogen, C 1 -C 20 alkyl, C 6 -C 12 aryl, cyclic alkyl, fluoro alkyl, and void;
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening, or free radical polymerization;
L is C or Si or void;
L 1 , L 3 , and L 4 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
L 2 is independently selected from —(CH 2 ) x —, or —(CH(CN)) x —, where x is an integer from 1 to 20;
A 1 is N;
B 1 is C, S, SO, PO, or PO 2 − ;
B 2 is C or SO;
M is selected from Cl, Br, I, SO 4 , NO 3 ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C 1 -C 20 alkyl), lactate, benzoate, salicylate, or void; and
j is an integer from 1 to about 1000.
6 . A macromonomer having a formula selected from the group consisting of:
wherein
R 1 and R 6 are selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C20 alkyl, C6-C12 aryl, CN, cyclic alkyl, fluoroalkyl, and void;
R 4 , R 5 , R 7 , and R 8 are independently selected from the group consisting of hydrogen, C1-C20 alkyl, C6-C12 aryl, cyclic alkyl, fluoroalkyl, and void;
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening, or free radical polymerization;
L 0 and L 4 are C or Si or void;
L 1 , L 2 , L 3 , L 5 , and L 6 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
A 1 is N;
B 1 is C, S, SO, PO, or PO 2 − ;
B 2 is C or SO;
C 1 is PO 4 ;
M is selected from Cl, Br, I, SO 4 , NO 3 ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C1-C20 alkyl), lactate, benzoate, and salicylate or void; and
j and k are integers independently selected from 1 to about 1000.
7 . A monomer having the formula:
or a salt thereof,
wherein
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening, or free radical polymerization;
X a is selected from —(CH 2 ) n —, where n is 0 to 6;
X b is —(CH 2 ) p —, where p is 1 to 6;
R a is selected from hydrogen and C1-C6 alkyl;
X c is —(CH 2 ) q —, where q is 1 to 6; and
Y is selected from CO 2 − , SO 3 − , or PO 4 2− .
8 . A monomer having the formula:
or a salt thereof,
wherein
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening, or free radical polymerization;
X a is selected from —(CH 2 ) n —, where n is 0 to 6;
X b is —(CH 2 ) p —, where p is 1 to 6;
R a , R b , and R c are independently selected from hydrogen and C 1 -C 6 alkyl;
X c is —(CH 2 ) q —, where q is 1 to 6;
X d is —(CH 2 ) r —, where r is 1 to 6; and
Y is selected from CO 2 − , SO 3 − , or PO 4 2− .
9 . A monomer having the formula:
or a salt thereof,
wherein
R 2 and R 3 are independently selected from a functional group suitable for polymerization by addition, condensation, or ring opening, or free radical polymerization;
X a is selected from —(CH 2 ) n —, where n is 0 to 6;
X b is —(CH 2 ) p —, where p is 1 to 6;
R a and R b are independently selected from hydrogen and C1-C6 alkyl; and
X c is —(CH 2 ) q —, where q is 1 to 6.
10 . The monomer of any one of claim 1 - 9 , wherein R 2 and R 3 are independently selected from the group consisting of F, Cl, Br, I, SH, protected thiols, NH 2 , —NH— (secondary amine), N═C═O, protected NCO, N═C═S, COOH, COSH, C(═S)SH, OCOOH, OCOSH, OC(═S)OH, SC(═O)SH, SC(═S)SH, N(C═O)NH 2 , N(C═NH)NH 2 , N(C═S)NH 2 , δ-valerolactone moiety, ε-caprolactone moiety, CH 2 ═CH—C(═O)—O—, CH 2 ═CH—C(═O)—NH—, CH 2 ═CH—C(═O)—S—, CN, CH 2 ═CH(CH 3 )—C(═O)—O—, CH 2 ═CH(CH 3 )—C(═O)—O—, OH, azides, alkynes, or void.
11 . The monomer of any one of claim 1 - 9 , wherein R 2 and R 3 are selected from the group consisting of —N═C═O and —N═C═S.
12 . The monomer of any one of claim 1 - 9 , wherein R 2 and R 3 are Michael acceptors selected from the group consisting of CH 2 ═CH—C(═O)—O—, CH 2 ═CH—C(═O)—NH—, CH 2 ═CH—C(═O)—S—, CH 2 ═CH(CH 3 )—C(═O)—O—, and CH 2 ═CH(CH 3 )—C(═O)—O—.
13 . The monomer of any one of claim 1 - 9 , wherein R 2 and R 3 are selected from the group consisting of
wherein
m and n are independently selected from 1 to 3.
R 4 and R 5 are independently selected from the group consisting of hydrogen, C 1 -C 20 alkyl, and C 6 -C 12 aryl, cyclic alkyl, fluoroalkyl, and void;
L 1 is independently selected from —(CH 2 ) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
L 2 is —(CH 2 ) x where x is an integer from 1 to 20;
A 1 is N;
B 2 is C or SO; and
M is selected from Cl, Br, I, SO 4 , NO 3 ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C 1 -C 20 alkyl), lactate, benzoate, and salicylate, or void.
14 . A monomer having the formula:
or a salt thereof,
wherein
X a is selected from —O(C═O)(CH 2 ) n — where n is 1 to 6, —O(CH 2 ) m — where m is 1 to 6, or is absent;
R a and R b are independently selected from hydrogen and C1-C6 alkyl; and
X b is —(CH 2 ) n — where n is 1 to 6.
15 . A monomer having the formula:
or a salt thereof,
wherein
X a is selected from —O(C═O)(CH 2 ) n —, where n is 1 to 6, or —NH(C═O)(CH 2 ) m —, where m is 1 to 6;
R a and R b are independently selected from hydrogen and C1-C6 alkyl; and
X b is —(CH 2 ) p —, where p is 1 to 6; and
X c is —(CH 2 ) q —, where q is 1 to 6.
16 . A monomer having the formula:
or a salt thereof,
wherein
X a is selected from —(CH 2 ) n —, where n is 0 to 6;
X b is —(CH 2 ) p —, where p is 1 to 6;
R a and R b are independently selected from hydrogen and C1-C6 alkyl; and
X c is —(CH 2 ) q —, where q is 1 to 6.
17 . A monomer having the formula:
or a salt thereof,
wherein
X a is selected from —(CH 2 ) n —, where n is 0 to 6;
X b is —(CH 2 ) p —, where p is 1 to 6;
R a and R b are independently selected from hydrogen and C1-C6 alkyl; and
X c is —(CH 2 ) q —, where q is 1 to 6.
18 . A polymer prepared by polymerizing a monomer of any one of claim 1 - 17 .
19 . A polymer prepared by polymerizing a monomer of any one of claim 1 - 17 with a second monomer.
20 . A polymer having the formula:
wherein
K 1 , K 2 , K 3 , and K 4 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
R 2 and R 3 are independently selected from H, F, Cl, Br, I, OH, SH, protected thiols, NH 2 , —NH— (secondary amine), N═C═O, N═C═S, COOH, COSH, C(═S)SH, OCOOH, OCOSH, OC(═S)OH, SC(═O)SH, SC(═S)SH, N(C═O)NH 2 , N(C═NH)NH 2 , N(C═S)NH 2 , δ-valerolactone moiety, ε-caprolactone moiety, CH 2 ═CH—C(═O)—O—, CH 2 ═CH—C(═O)—NH—, CH 2 ═CH—C(═O)—S—, CN, CH 2 ═CH(CH 3 )—C(═O)—O—, CH 2 ═CH(CH 3 )—C(═O)—NH—, or void;
n is an integer from 5 to about 10,000;
j is an integer from 1 to about 1000;
M 1 and M 2 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void; and
Z and X are independently selected from zwitterionic groups.
21 . The polymer of claim 20 , wherein the Z and X are independently selected from the group consisting of
wherein
R 1 and R 8 are selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C20 alkyl, and C6-C12 aryl groups, CN;
R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of hydrogen, C1-C20 alkyl, C6-C12 aryl, cyclic alkyl, fluoroalkyl, or void;
L is C or Si or void;
L 1 , L 3 , L 4 , and L 5 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
L 2 is independently selected from —(CH 2 ) x —, or —(CH(CN)) x —, where x is an integer from 1 to 20;
A 1 is N;
B 1 is C, S, SO, PO, or PO 2 − ;
B 2 is C or SO;
C 1 is PO 4 ; and
M is selected from Cl, Br, I, SO 4 , NO 3 , ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C1-C20 alkyl), lactate, benzoate, salicylate, or void.
22 . A polymer having the formula selected from the group consisting of:
wherein
R 1 and R 5 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C 1 -C 20 alkyl, and C 6 -C 12 aryl groups, CN;
R 2 , R 3 , R 4 , and R 6 are independently selected from the group consisting of hydrogen, C 1 -C 20 alkyl, C 6 -C 12 aryl, cyclic alkyl, fluoroalkyl, or void;
L 0 and L 5 are independently C or Si or void;
L 1 , L 2 , L 3 , L 4 , L 6 , and L 7 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
M 1 and M 2 are independently selected from the group consisting of —O—(CH 2 ) n —, —S—(CH 2 ) n —, —C(═O)—(CH 2 ) n —, —C(═S)—(CH 2 ) n —, —C(═NH)—(CH 2 ) n — and —NH—(CH 2 ) n —, wherein n is an integer from 1 to 20; —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, combinations thereof, or void;
B 1 is C, S, SO, P, or PO;
B 2 is C or SO;
A 1 is N, S, or P;
M is selected from Cl, Br, I, SO 4 , NO 3 ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C 1 -C 20 alkyl), lactate, benzoate, salicylate, or void;
wherein the ratio between m and n is selected from 0.8 to 1.2; and
wherein m and n are independently integers from 1 to about 10,000.
23 . A polymer of any one of claim 18 - 22 having a fibrinogen binding level of less than 30 ng/cm 2 in a fibrinogen binding assay (polymer surface is incubated at 37° C. for 90 minutes with a 1.0 mg/mL fibrinogen solution in 0.15 M phosphate buffered saline at pH 7.4).
24 . A polymer of any one of claim 18 - 22 having a tensile or compressive strength greater than 0.5 MPa.
25 . A polymer of any one of claim 18 - 22 having a fibrinogen binding level of less than 30 ng/cm 2 in a fibrinogen binding assay (polymer surface is incubated at 37° C. for 90 minutes with a 1.0 mg/mL fibrinogen solution in 0.15 M phosphate buffered saline at pH 7.4) and a tensile or compressive strengths greater than 0.5 MPa.
26 . A polymer of any one of claim 18 - 22 , wherein the polymer is crosslinked.
27 . A composite, comprising a polymer of any one of claim 18 - 22 and a second polymer.
28 . The composite of claim 27 , wherein the second polymer is selected from the group consisting of polyesters, polycarbonates, polyurethanes, polyureas, polysulfides, polysulfones, polyimides, polyepoxies, aromatic polyesters, cellulosics, fluoropolymers, polyacrylics, polyamides, polyanhydrides, polyethers, vinyl polymers, phenolics, elastomers, and other addition polymers.
29 . The composite of claim 27 further comprising a strength additive.
30 . The composite of claim 27 further comprising a strength additive selected from the groups consisting of fiber, clays, nanotubes, and other inorganic objects.
31 . A polymer of any one of claim 18 - 22 formed into an object by a method selected from the group consisting of injection molding, blow molding, extrusion molding, calendaring molding, flow casting, compression molding, prevarication molding, and 3D printing.
32 . A surface coating for a substrate, comprising a polymer of any one of claim 18 - 22 .
33 . The surface coating of claim 32 , wherein the substrate is a consumer product.
34 . The surface coating of claim 32 , wherein the substrate is a marine product.
35 . The surface coating of claim 32 , wherein the substrate is a marine product selected from the group consisting of marine vessel hulls, marine structures, bridges, propellers, heat exchangers, periscopes, sensors, fish nets, cables, tubes/pipes, containers, membranes, and oil booms.
36 . The surface coating of claim 32 , wherein the substrate is a biomedical product.
37 . The surface coating of claim 32 , wherein the substrate is a biomedical product selected from the group consisting of catheters, ear drainage tubes, feeding tubes, glaucoma drainage tubes, hydrocephalous shunts, keratoprosthesis, nerve guidance tubes, tissue adhesives, x-ray guides, artificial joints, artificial heart valves, artificial blood vessels, pacemakers, left ventricular assist devices (LVAD), artery grafts, vascular grafts, stents, intravascular stents, cardiac valves, joint replacements, blood vessel prostheses, skin repair devices, cochlear replacements, contact lenses, artificial ligaments and tendons, dental implants, and tissue scaffolds for regenerative tissue engineering.
38 . The surface coating of claim 32 , wherein the substrate is a delivery vehicle selected from the group consisting of a drug delivery vehicle, a gene delivery vehicle, an RNA delivery vehicle, a protein delivery vehicle.
39 . A polymer of any one of claim 18 - 22 coupled to a biomolecule.
40 . The polymer of claim 39 , wherein the biomolecule is a therapeutic agent, a nucleic acid (e.g., a gene or DNA or RNA), a protein (e.g., antibody or functional fragment thereof), a lipid, a peptide, or a small molecule having a molecular weight less than about 800.
41 . A polymer of any one of claim 18 - 22 coupled to a cell or microorganism.
42 . A polymer of any one of claim 18 - 22 coupled to a nanoparticle.
43 . The polymer of claim 42 , wherein the nanoparticle is a liposome or a micelle.
44 . The polymer of claim 42 , wherein the nanoparticle is a quantum dot.
45 . The polymer of claim 42 , wherein the nanoparticle is an iron oxide, silica, or gold nanoparticle.
46 . A bulk material comprising a polymer of any one of claim 18 - 22 , wherein the bulk material is formed into an object by a method selected from the group consisting of injection molding, blow molding, extrusion molding, calendaring molding, flow casting, compression molding, prevarication molding, and 3D printing.
47 . A surface coating for a substrate, comprising a bulk material comprising a polymer of any one of claim 18 - 22 .
48 . The surface coating of claim 47 , wherein the substrate is a consumer product.
49 . The surface coating of claim 47 , wherein the substrate is a marine product.
50 . The surface coating of claim 47 , wherein the substrate is a marine product selected from the group consisting of marine vessel hulls, marine structures, bridges, propellers, heat exchangers, periscopes, sensors, fish nets, cables, tubes/pipes, containers, membranes, and oil booms.Join the waitlist — get patent alerts
Track US2023124554A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.